Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
出版年份 2018 全文链接
标题
Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
作者
关键词
Multiple sclerosis, Lesions, Magnetic resonance imaging, Switzerland, Yeast infections, B cells, Observational studies, White blood cells
出版物
PLoS One
Volume 13, Issue 5, Pages e0197415
出版商
Public Library of Science (PLoS)
发表日期
2018-05-15
DOI
10.1371/journal.pone.0197415
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
- (2017) Tomas Kalincik et al. LANCET NEUROLOGY
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice
- (2017) Hjalmar Wadström et al. JAMA Internal Medicine
- Rituximab versus fingolimod after natalizumab in multiple sclerosis patients
- (2016) Peter Alping et al. ANNALS OF NEUROLOGY
- Disease activity return after natalizumab cessation in multiple sclerosis
- (2016) Maria Rasenack et al. Expert Review of Neurotherapeutics
- MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
- (2016) Massimo Filippi et al. LANCET NEUROLOGY
- Rituximab in multiple sclerosis
- (2016) Jonatan Salzer et al. NEUROLOGY
- Disease activity return after natalizumab cessation in multiple sclerosis
- (2016) Maria Rasenack et al. Expert Review of Neurotherapeutics
- Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients
- (2014) Per Soelberg Sorensen et al. JOURNAL OF NEUROLOGY
- Glatiramer Acetate in the Treatment of Multiple Sclerosis
- (2011) Patrice H. Lalive et al. CNS DRUGS
- Comparative study of mitoxantrone efficacy profile in patients with relapsing—remitting and secondary progressive multiple sclerosis
- (2010) Federica Esposito et al. Multiple Sclerosis Journal
- Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial
- (2010) R. T. Naismith et al. NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety of Biologic Therapy in Rheumatoid Arthritis and Other Autoimmune Diseases: Focus on Rituximab
- (2008) Roy M. Fleischmann SEMINARS IN ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now